Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

The progression of myopia in school-age children: data from the Columbia Medical Plan,

Go back to Resources

The progression of myopia in school-age children: data from the Columbia Medical Plan,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The overlapping coefficient for two normal probability functions with unequal variances.

Go back to Resources

The overlapping coefficient for two normal probability functions with unequal variances.

Authors:

Location:

Go back to Resources

The effects of treatment noncompliance on power in a 2x2 factorial design,

Go back to Resources

The effects of treatment noncompliance on power in a 2x2 factorial design,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity,

Go back to Resources

The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity,

Authors:

Location:

Go back to Resources

Steady improvement in post 1 year half-life of pediatric renal transplants,

Go back to Resources

Steady improvement in post 1 year half-life of pediatric renal transplants,

Authors:

Location:

Go back to Resources

Practical Issues in the Design and Analysis of the Quality of Life Study in the Unrelated Donor Marrow Transplantation Trial.

Go back to Resources

Practical Issues in the Design and Analysis of the Quality of Life Study in the Unrelated Donor Marrow Transplantation Trial.

Authors:

Location:

Go back to Resources

Post transplant diabetes mellitus in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

Post transplant diabetes mellitus in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Location:

Go back to Resources

Plasma concentrations and pharmacokinetics of dimethylsulfoxide and metabolites in patients undergoing peripheral stem-cell transplants

Go back to Resources

Plasma concentrations and pharmacokinetics of dimethylsulfoxide and metabolites in patients undergoing peripheral stem-cell transplants

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Much Ado About Not Enough Data: Breast Cancer Transplantation in the 90's

Go back to Resources

Much Ado About Not Enough Data: Breast Cancer Transplantation in the 90's

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Malignancy and post-transplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

Malignancy and post-transplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 110
  • Page 111
  • Page 112
  • Page 113
  • Current page 114
  • Page 115
  • Page 116
  • Page 117
  • Page 118
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification